{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:25:46Z","timestamp":1792808746561,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20240728"],"award-info":[{"award-number":["20240728"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06135-9","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T16:23:21Z","timestamp":1738081401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["UBE2J1 is identified as a novel plasma cell-related gene involved in the prognosis of high-grade serous ovarian cancer"],"prefix":"10.1186","volume":"23","author":[{"given":"Yunjie","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxia","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7790-2393","authenticated-orcid":false,"given":"Shan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"6135_CR1","doi-asserted-by":"publisher","first-page":"eadi2556","DOI":"10.1126\/scitranslmed.adi2556","volume":"15","author":"L Paracchini","year":"2023","unstructured":"Paracchini L, Mannarino L, Romualdi C, Zadro R, Beltrame L, Fuso Nerini I, et al. Genomic instability analysis in DNA from papanicolaou test provides proof-of-principle early diagnosis of high-grade serous ovarian cancer. Sci Transl Med. 2023;15:eadi2556.","journal-title":"Sci Transl Med"},{"key":"6135_CR2","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1038\/s41467-023-41820-7","volume":"14","author":"M Crispin-Ortuzar","year":"2023","unstructured":"Crispin-Ortuzar M, Woitek R, Reinius MAV, Moore E, Beer L, Bura V, et al. Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer. Nat Commun. 2023;14:6756.","journal-title":"Nat Commun"},{"key":"6135_CR3","doi-asserted-by":"publisher","first-page":"189052","DOI":"10.1016\/j.bbcan.2023.189052","volume":"1879","author":"V Tadi\u0107","year":"2024","unstructured":"Tadi\u0107 V, Zhang W, Brozovic A. The high-grade serous ovarian cancer metastasis and chemoresistance in 3D models. Biochim Biophys Acta Rev Cancer. 2024;1879:189052.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"6135_CR4","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1056\/NEJMoa2309169","volume":"389","author":"KN Moore","year":"2023","unstructured":"Moore KN, Angelergues A, Konecny GE, Garc\u00eda Y, Banerjee S, Lorusso D, et al. Mirvetuximab soravtansine in FR\u03b1-positive, platinum-resistant ovarian cancer. N Engl J Med. 2023;389:2162\u201374.","journal-title":"N Engl J Med"},{"key":"6135_CR5","doi-asserted-by":"publisher","first-page":"e174013","DOI":"10.1172\/JCI174013","volume":"134","author":"Y Wang","year":"2024","unstructured":"Wang Y, Duval AJ, Adli M, Matei D. Biology-driven therapy advances in high-grade serous ovarian cancer. J Clin Invest. 2024;134:e174013.","journal-title":"J Clin Invest"},{"key":"6135_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13048-024-01482-5","volume":"17","author":"S Sarkar","year":"2024","unstructured":"Sarkar S, Saha SA, Swarnakar A, Chakrabarty A, Dey A, Sarkar P, et al. The molecular prognostic score, a classifier for risk stratification of high-grade serous ovarian cancer. J Ovarian Res. 2024;17:159.","journal-title":"J Ovarian Res"},{"key":"6135_CR7","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1016\/j.trecan.2023.08.004","volume":"9","author":"M Toninelli","year":"2023","unstructured":"Toninelli M, Rossetti G, Pagani M. Charting the tumor microenvironment with spatial profiling technologies. Trends Cancer. 2023;9:1085\u201396.","journal-title":"Trends Cancer"},{"key":"6135_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3390\/biom14040438","volume":"14","author":"X Zhang","year":"2024","unstructured":"Zhang X, Ma H, Gao Y, Liang Y, Du Y, Hao S, et al. The tumor microenvironment: signal transduction. Biomolecules. 2024;14:438.","journal-title":"Biomolecules"},{"key":"6135_CR9","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s41590-023-01678-9","volume":"24","author":"LA Walsh","year":"2023","unstructured":"Walsh LA, Quail DF. Decoding the tumor microenvironment with spatial technologies. Nat Immunol. 2023;24:1982\u201393.","journal-title":"Nat Immunol"},{"key":"6135_CR10","doi-asserted-by":"publisher","first-page":"102996","DOI":"10.1016\/j.copbio.2023.102996","volume":"84","author":"F Chen","year":"2023","unstructured":"Chen F, Dowerg B, Cordes T. The yin and yang of itaconate metabolism and its impact on the tumor microenvironment. Curr Opin Biotechnol. 2023;84:102996.","journal-title":"Curr Opin Biotechnol"},{"key":"6135_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41467-022-28389-3","volume":"13","author":"IM Launonen","year":"2022","unstructured":"Launonen IM, Lyytik\u00e4inen N, Casado J, Anttila EA, Szab\u00f3 A, Haltia UM, et al. Single-cell tumor-immune microenvironment of BRCA1\/2 mutated high-grade serous ovarian cancer. Nat Commun. 2022;13:835.","journal-title":"Nat Commun"},{"key":"6135_CR12","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1158\/1078-0432.CCR-22-0296","volume":"28","author":"J Xu","year":"2022","unstructured":"Xu J, Fang Y, Chen K, Li S, Tang S, Ren Y, et al. Single-cell RNA sequencing reveals the tissue architecture in human high-grade serous ovarian cancer. Clin Cancer Res. 2022;28:3590\u2013602.","journal-title":"Clin Cancer Res"},{"key":"6135_CR13","doi-asserted-by":"publisher","first-page":"100856","DOI":"10.1016\/j.xcrm.2022.100856","volume":"3","author":"B Yang","year":"2022","unstructured":"Yang B, Li X, Zhang W, Fan J, Zhou Y, Li W, et al. Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis. Cell Rep Med. 2022;3:100856.","journal-title":"Cell Rep Med"},{"key":"6135_CR14","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1158\/1078-0432.CCR-11-2725","volume":"18","author":"K Yoshihara","year":"2012","unstructured":"Yoshihara K, Tsunoda T, Shigemizu D, Fujiwara H, Hatae M, Fujiwara H, et al. High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway. Clin Cancer Res. 2012;18:1374\u201385.","journal-title":"Clin Cancer Res"},{"key":"6135_CR15","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.cell.2017.09.028","volume":"171","author":"N Riaz","year":"2017","unstructured":"Riaz N, Havel JJ, Makarov V, Desrichard A, Urba WJ, Sims JS, et al. Tumor and microenvironment evolution during immunotherapy with nivolumab. Cell. 2017;171:934\u201349.","journal-title":"Cell"},{"key":"6135_CR16","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-019-0969-x","volume":"566","author":"J Cao","year":"2019","unstructured":"Cao J, Spielmann M, Qiu X, Huang X, Ibrahim DM, Hill AJ, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature. 2019;566:496\u2013502.","journal-title":"Nature"},{"key":"6135_CR17","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun. 2021;12:1088.","journal-title":"Nat Commun"},{"key":"6135_CR18","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12967-023-04151-1","volume":"21","author":"F Long","year":"2023","unstructured":"Long F, Wang W, Li S, Wang B, Hu X, Wang J, et al. The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer. J Transl Med. 2023;21:298.","journal-title":"J Transl Med"},{"key":"6135_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13058-021-01477-w","volume":"23","author":"A Sakaguchi","year":"2021","unstructured":"Sakaguchi A, Horimoto Y, Onagi H, Ikarashi D, Nakayama T, Nakatsura T, et al. Plasma cell infiltration and treatment effect in breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res. 2021;23:99.","journal-title":"Breast Cancer Res"},{"key":"6135_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/nm.3909","volume":"21","author":"AJ Gentles","year":"2015","unstructured":"Gentles AJ, Newman AM, Liu CL, Bratman SV, Feng W, Kim D, et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat Med. 2015;21:938\u201345.","journal-title":"Nat Med"},{"key":"6135_CR21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/cac2.12511","volume":"44","author":"M Raab","year":"2024","unstructured":"Raab M, Kostova I, Pe\u00f1a-Llopis S, Fietz D, Kressin M, Aberoumandi SM, et al. Rescue of p53 functions by in vitro-transcribed mRNA impedes the growth of high-grade serous ovarian cancer. Cancer Commun. 2024;44:101\u201326.","journal-title":"Cancer Commun"},{"key":"6135_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1200\/OP.22.00461","volume":"19","author":"CA Penn","year":"2023","unstructured":"Penn CA, Alvarez RD. Current issues in the management of patients with newly diagnosed advanced-stage high-grade serous carcinoma of the ovary. JCO Oncol Pract. 2023;19:116\u201322.","journal-title":"JCO Oncol Pract"},{"key":"6135_CR23","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41586-024-07047-2","volume":"626","author":"M Ishikawa","year":"2024","unstructured":"Ishikawa M, Hasanali ZS, Zhao Y, Das A, Lavaert M, Roman CJ, et al. Bone marrow plasma cells require P2RX4 to sense extracellular ATP. Nature. 2024;626:1102\u20137.","journal-title":"Nature"},{"key":"6135_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13073-021-00922-x","volume":"13","author":"S Olbrecht","year":"2021","unstructured":"Olbrecht S, Busschaert P, Qian J, Vanderstichele A, Loverix L, Van Gorp T, et al. High-grade serous tubo-ovarian cancer refined with single-cell RNA sequencing: specific cell subtypes influence survival and determine molecular subtype classification. Genome Med. 2021;13:111.","journal-title":"Genome Med"},{"key":"6135_CR25","doi-asserted-by":"publisher","first-page":"eabb0737","DOI":"10.1126\/sciadv.abb0737","volume":"7","author":"Z Yang","year":"2021","unstructured":"Yang Z, Wang W, Zhao L, Wang X, Gimple RC, Xu L, et al. Plasma cells shape the mesenchymal identity of ovarian cancers through transfer of exosome-derived microRNAs. Sci Adv. 2021;7:eabb0737.","journal-title":"Sci Adv"},{"key":"6135_CR26","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.2337\/db21-1128","volume":"71","author":"Q Tang","year":"2022","unstructured":"Tang Q, Liu Q, Li J, Yan J, Jing X, Zhang J, et al. MANF in POMC neurons promotes brown adipose tissue thermogenesis and protects against diet-induced obesity. Diabetes. 2022;71:2344\u201359.","journal-title":"Diabetes"},{"key":"6135_CR27","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/s41467-017-00750-x","volume":"8","author":"S Yang","year":"2017","unstructured":"Yang S, Yang H, Chang R, Yin P, Yang Y, Yang W, et al. MANF regulates hypothalamic control of food intake and body weight. Nat Commun. 2017;8:579.","journal-title":"Nat Commun"},{"key":"6135_CR28","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/hep.30917","volume":"71","author":"J Liu","year":"2020","unstructured":"Liu J, Wu Z, Han D, Wei C, Liang Y, Jiang T, et al. Mesencephalic astrocyte-derived neurotrophic factor inhibits liver cancer through small ubiquitin-related modifier (SUMO)ylation-related suppression of NF-\u03baB\/Snail signaling pathway and epithelial-mesenchymal transition. Hepatology. 2020;71:1262\u201378.","journal-title":"Hepatology"},{"key":"6135_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1007\/s11033-024-09602-6","volume":"51","author":"M Huang","year":"2024","unstructured":"Huang M, Hu J, Chen Y, Xun Y, Zhang X, Cao Y. Mesencephalic astrocyte-derived neurotrophic factor inhibits cervical cancer progression via regulating macrophage phenotype. Mol Biol Rep. 2024;51:654.","journal-title":"Mol Biol Rep"},{"key":"6135_CR30","doi-asserted-by":"publisher","first-page":"900166","DOI":"10.3389\/fonc.2022.900166","volume":"12","author":"YM Chu","year":"2022","unstructured":"Chu YM, Xu Y, Zou XQ, Zhou FL, Deng YL, Han YT, et al. DLC1 inhibits colon adenocarcinoma cell migration by promoting secretion of the neurotrophic factor MANF. Front Oncol. 2022;12:900166.","journal-title":"Front Oncol"},{"key":"6135_CR31","doi-asserted-by":"publisher","first-page":"9169","DOI":"10.2147\/OTT.S245575","volume":"13","author":"J He","year":"2020","unstructured":"He J, Li G, Liu X, Ma L, Zhang J, Zheng S, et al. Mesencephalic astrocyte-derived neurotrophic factor, a prognostic factor of cholangiocarcinoma, affects sorafenib sensitivity of cholangiocarcinoma cells by deteriorating ER stress. Onco Targets Ther. 2020;13:9169\u201384.","journal-title":"Onco Targets Ther"},{"key":"6135_CR32","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1038\/s41591-023-02491-5","volume":"29","author":"H Lee","year":"2023","unstructured":"Lee H, Ahn S, Maity R, Leblay N, Ziccheddu B, Truger M, et al. Mechanisms of antigen escape from BCMA- or GPRC5D-targeted immunotherapies in multiple myeloma. Nat Med. 2023;29:2295\u2013306.","journal-title":"Nat Med"},{"key":"6135_CR33","doi-asserted-by":"publisher","first-page":"941208","DOI":"10.3389\/fonc.2022.941208","volume":"12","author":"Y Song","year":"2022","unstructured":"Song Y, Zhang Z, Zhang B, Zhang W. CD8+ T cell-associated genes MS4A1 and TNFRSF17 are prognostic markers and inhibit the progression of colon cancer. Front Oncol. 2022;12:941208.","journal-title":"Front Oncol"},{"key":"6135_CR34","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/s12885-024-12227-4","volume":"24","author":"M He","year":"2024","unstructured":"He M, Jiang W, Li X, Liu H, Ren H, Lin Y. 25-hydroxycholesterol promotes proliferation and metastasis of lung adenocarcinoma cells by regulating ER\u03b2\/TNFRSF17 axis. BMC Cancer. 2024;24:505.","journal-title":"BMC Cancer"},{"key":"6135_CR35","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.3390\/nu14071409","volume":"14","author":"S Gharanei","year":"2022","unstructured":"Gharanei S, Ramanjaneya M, Patel AH, Patel V, Shabir K, Auld C, et al. NUCB2\/nesfatin-1 reduces obesogenic diet induced inflammation in mice subcutaneous white adipose tissue. Nutrients. 2022;14:1409.","journal-title":"Nutrients"},{"key":"6135_CR36","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s13105-022-00895-4","volume":"78","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Liu Y, Feng R, Zhang W. NUCB2: roles in physiology and pathology. J Physiol Biochem. 2022;78:603\u201317.","journal-title":"J Physiol Biochem"},{"key":"6135_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1186\/s12967-023-04385-z","volume":"21","author":"S Ning","year":"2023","unstructured":"Ning S, Liu C, Wang K, Cai Y, Ning Z, Li M, et al. NUCB2\/Nesfatin-1 drives breast cancer metastasis through the up-regulation of cholesterol synthesis via the mTORC1 pathway. J Transl Med. 2023;21:524.","journal-title":"J Transl Med"},{"key":"6135_CR38","doi-asserted-by":"publisher","first-page":"216893","DOI":"10.1016\/j.canlet.2024.216893","volume":"591","author":"R Ji","year":"2024","unstructured":"Ji R, Wang Y, Pan D, Han J, Wang Y, Zheng S, et al. NUCB2 inhibition antagonizes osteosarcoma progression and promotes anti-tumor immunity through inactivating NUCKS1\/CXCL8 axis. Cancer Lett. 2024;591:216893.","journal-title":"Cancer Lett"},{"key":"6135_CR39","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.2147\/OTT.S184560","volume":"12","author":"J Zhao","year":"2019","unstructured":"Zhao J, Yun X, Ruan X, Chi J, Yu Y, Li Y, et al. High expression of NUCB2 promotes papillary thyroid cancer cells proliferation and invasion. Onco Targets Ther. 2019;12:1309\u201318.","journal-title":"Onco Targets Ther"},{"key":"6135_CR40","first-page":"2425","volume":"15","author":"H Xu","year":"2018","unstructured":"Xu H, Li W, Qi K, Zhou J, Gu M, Wang Z. A novel function of NUCB2 in promoting the development and invasion of renal cell carcinoma. Oncol Lett. 2018;15:2425\u201330.","journal-title":"Oncol Lett"},{"key":"6135_CR41","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1158\/0008-5472.CAN-08-1360","volume":"68","author":"I Bernard-Pierrot","year":"2008","unstructured":"Bernard-Pierrot I, Gruel N, Stransky N, Vincent-Salomon A, Reyal F, Raynal V, et al. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer. Cancer Res. 2008;68:7165\u201375.","journal-title":"Cancer Res"},{"key":"6135_CR42","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.ajpath.2013.07.028","volume":"183","author":"SF Mahmood","year":"2013","unstructured":"Mahmood SF, Gruel N, Nicolle R, Chapeaublanc E, Delattre O, Radvanyi F, et al. PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors. Am J Pathol. 2013;183:1634\u201344.","journal-title":"Am J Pathol"},{"key":"6135_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1006\/bbrc.2000.4111","volume":"280","author":"S Fukuda","year":"2001","unstructured":"Fukuda S, Sumii M, Masuda Y, Takahashi M, Koike N, Teishima J, et al. Murine and human SDF2L1 is an endoplasmic reticulum stress-inducible gene and encodes a new member of the Pmt\/rt protein family. Biochem Biophys Res Commun. 2001;280:407\u201314.","journal-title":"Biochem Biophys Res Commun"},{"key":"6135_CR44","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41467-019-08591-6","volume":"10","author":"T Sasako","year":"2019","unstructured":"Sasako T, Ohsugi M, Kubota N, Itoh S, Okazaki Y, Terai A, et al. Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism. Nat Commun. 2019;10:947.","journal-title":"Nat Commun"},{"key":"6135_CR45","doi-asserted-by":"publisher","first-page":"19335","DOI":"10.1074\/jbc.RA119.009603","volume":"294","author":"K Hanafusa","year":"2019","unstructured":"Hanafusa K, Wada I, Hosokawa N. SDF2-like protein 1 (SDF2L1) regulates the endoplasmic reticulum localization and chaperone activity of ERdj3 protein. J Biol Chem. 2019;294:19335\u201348.","journal-title":"J Biol Chem"},{"key":"6135_CR46","doi-asserted-by":"publisher","first-page":"9898479","DOI":"10.1155\/2022\/9898479","volume":"2022","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhang Z, Qin L, Shi X, Su Q, Mo W. SDF2L1 Inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma. Biomed Res Int. 2022;2022:9898479.","journal-title":"Biomed Res Int"},{"key":"6135_CR47","doi-asserted-by":"publisher","first-page":"117693432210958","DOI":"10.1177\/11769343221095862","volume":"18","author":"C Luo","year":"2022","unstructured":"Luo C, Zhang Z, Su Q, Mo W. Identification of phosphorylated proteins regulated by SDF2L1 in nasopharyngeal carcinoma cells. Evol Bioinform Online. 2022;18:11769343221095862.","journal-title":"Evol Bioinform Online"},{"key":"6135_CR48","doi-asserted-by":"publisher","first-page":"4616","DOI":"10.1093\/hmg\/ddt310","volume":"22","author":"BD Roussel","year":"2013","unstructured":"Roussel BD, Newton TM, Malzer E, Simecek N, Haq I, Thomas SE, et al. Sterol metabolism regulates neuroserpin polymer degradation in the absence of the unfolded protein response in the dementia FENIB. Hum Mol Genet. 2013;22:4616\u201326.","journal-title":"Hum Mol Genet"},{"key":"6135_CR49","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fcell.2020.00310","volume":"8","author":"R Kavarthapu","year":"2020","unstructured":"Kavarthapu R, Anbazhagan R, Sharma AK, Shiloach J, Dufau ML. Linking phospho-gonadotropin regulated testicular RNA helicase (GRTH\/DDX25) to histone ubiquitination and acetylation essential for spermatid development during spermiogenesis. Front Cell Dev Biol. 2020;8:310.","journal-title":"Front Cell Dev Biol"},{"key":"6135_CR50","doi-asserted-by":"publisher","first-page":"34490","DOI":"10.1074\/jbc.M114.604132","volume":"289","author":"PA Koenig","year":"2014","unstructured":"Koenig PA, Nicholls PK, Schmidt FI, Hagiwara M, Maruyama T, Frydman GH, et al. The E2 ubiquitin-conjugating enzyme UBE2J1 is required for spermiogenesis in mice. J Biol Chem. 2014;289:34490\u2013502.","journal-title":"J Biol Chem"},{"key":"6135_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-024-01141-6","author":"J Shi","year":"2024","unstructured":"Shi J, Tang J, Liu L, Zhang C, Chen W, Qi M, et al. Integrative analyses of bulk and single-cell RNA seq identified the shared genes in acute respiratory distress syndrome and rheumatoid arthritis. Mol Biotechnol. 2024. https:\/\/doi.org\/10.1007\/s12033-024-01141-6.","journal-title":"Mol Biotechnol"},{"key":"6135_CR52","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41388-022-02581-7","volume":"42","author":"T Wang","year":"2023","unstructured":"Wang T, Jin C, Yang P, Chen Z, Ji J, Sun Q, et al. UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene. 2023;42:651\u201364.","journal-title":"Oncogene"},{"key":"6135_CR53","doi-asserted-by":"publisher","first-page":"20220567","DOI":"10.1515\/med-2022-0567","volume":"18","author":"P Zhang","year":"2023","unstructured":"Zhang P, Guo H, Zhao F, Jia K, Yang F, Liu X. UBE2J1 knockdown promotes cell apoptosis in endometrial cancer via regulating PI3K\/AKT and MDM2\/p53 signaling. Open Med. 2023;18:20220567.","journal-title":"Open Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06135-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06135-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T03:59:25Z","timestamp":1738123165000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06135-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6135"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06135-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments were conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the Fourth Hospital of Hebei Medical University (Approval no. 2023KS157, Approval date: 29\/12\/2023). Informed consents were obtained from all individuals involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"129"}}